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Technology and Research, Matrix, SingaporeABSTRACT Amidehydrogen-deuteriumexchangemass spectrometry is powerful for describing combinatorial couplingeffectsof
a cooperative ligand pair binding at noncontiguous sites: adenosine at the ATP-pocket and a docking peptide (PIFtide) at the PIF-
pocket, on amodel protein kinase PDK1. Binding of two ligands to PDK1 revealmultiple hotspots of synergistic allosterywith cumu-
lative effects greater than the sumof individual effectsmediated by each ligand.Wequantified this synergismand ranked these hot-
spots using a difference in deuteration-based approach, which showed that the strongest synergistic effectswere observed at three
of the critical catalytic loci of kinases: the aB-aC helices, and HRD-motif loop, and DFG-motif. Additionally, we observed weaker
synergistic effects at a distal GHI-subdomain locus. Synergistic changes in deuterium exchange observed at a distal site but not
at the intermediatesitesof the large lobeof the kinase revealsallosteric propagation inproteins tooperate through twomodes.Direct
electrostatic interactions between polar and charged amino acids thatmediate targeted relay of allosteric signals, and diffused relay
of allosteric signals throughsoftmatter-likehydrophobic coreaminoacids.Furthermore,weprovideevidence that the conservedb-3
strand lysine of protein kinases (Lys111 of PDK1) functions as an integrator node to coordinate allosteric coupling of the two ligand-
bindingsites. Itmaintains indirect interactionswith theATP-pocketandmediatesacritical salt bridgewithaglutamate (Glu130)ofaC
helix,which is conservedacrossall kinases. In summary, allosteric propagation in cooperative, dual-ligandedenzyme targets is bidi-
rectional and synergistic and offers a strategy for combinatorial drug development.SIGNIFICANCE Rational drug design has traditionally targeted orthosteric sites for common biological ligands such as
nucleotides. Loss of specificity is a major disadvantage in such an approach. Allosteric site(s) offer an alternative, and a
combination of orthosteric targeting and allosteric drugs offer greater potency and specificity. However, in vitro quantitation
of the combinatorial effects of two or more drugs targeting a common protein has remained a challenge. We present a
simple method to quantify combinatorial effects in a dual-liganded kinase model by hydrogen-deuterium exchange mass
spectrometry. This method is easily scalable for proteins with more than two ligands, as well as for rapid pairwise screening
of candidate molecules.INTRODUCTION
Allostery is a fundamental property of all proteins enabling
protein-ligand-protein interactions at a primary binding site
to alter the binding properties of a second ligand at a distal,
noncontiguous site (1), thereby playing a central role in
executing and regulating cellular functions (2). All long-
range conformational changes accompanying protein-ligand
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creativecommons.org/licenses/by-nc-nd/4.0/).allosteric changes (1,3,4). Dynamics is inherently linked
to protein allostery (5,6) and a complete thermodynamic
description of allostery requires measurement of both en-
thalpic (protein-ligand interface) as well as entropic
(conformational dynamics) components (7). A molecular
understanding of allostery is achieved by combining high-
resolution structural maps from static crystallographic and
cryogenic electron microscopy models with conformational
dynamics measurements across multiple timescales. Map-
ping combinatorial allostery in enzymes interacting with
more than one ligand across space requires a deconvolution
of multiple allosteric networks, making it a bigger challenge
(8–12).Biophysical Journal 119, 1833–1848, November 3, 2020 1833
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(HDXMS) is a powerful technique for mapping allostery in
single proteins and large multiprotein assemblies (13–17).
Deuterium exchange is initiated by dilution of an aqueous
sample protein in an equivalent buffer constituted in heavy
water (D2O) (seconds to minutes), followed by lowering
of pHread 2.5 and endoprotease-mediated proteolysis fol-
lowed by mass spectrometry (13,18,19). A major advantage
of HDXMS in mapping protein-ligand interactions is that it
offers both a direct readout of interacting residues at the
interface and accompanying conformational changes. Allo-
stery in single-ligand systems is readily identifiable when
increases in deuterium exchange are observed in loci upon
ligand binding (20). In the absence of mutagenesis or other
biophysical measurements, it is harder to distinguish be-
tween orthosteric and allosteric effects when predominantly
decreased exchange is observed across the entire protein in
the liganded state. In these instances, allosteric sites can be
distinguished from changes at orthosteric sites by inte-
grating HDXMS and x-ray crystallography or cryogenic
electron microscopy maps. Although structures provide
high-resolution maps of the protein-ligand interface,
HDXMS changes distal to the interface are attributable to
allostery (14). For biological ligands with multiple func-
tional groups interacting with the target protein, relative
contributions to the overall strength of the interaction can
be deconstructed with HDXMS carried out in variable con-
centrations of urea (21). Characterizing allostery in multili-
ganded systems (combinatorial allostery) represents a
bigger challenge because of knowledge gaps in ligand coop-
erativity, in which studies of individual ligand-bound states
are insufficient to fully describe allosteric effects in
multiply-liganded states. Here, we describe combinatorial
allostery from two ligands interacting at noncontiguous sites
in a model protein kinase 3-phosphoinositide-dependent
protein kinase 1 (PDK1) by HDXMS.
Protein kinases are a large important family of enzymes
that catalyze phosphotransfer to protein substrates. Kinases
have conserved structural scaffolds, consisting of a smaller
N-terminal and a larger C-terminal lobe. The N-lobe harbors
a characteristic ATP-binding pocket with conserved resi-
dues that catalyze the transfer of ATP’s g-phosphate to the
acceptor residues in substrates (22–24). Protein kinases
are key mediators in numerous cellular processes and their
dysfunction has been linked to cancer, diabetes, and neuro-
logical and inflammatory diseases (25). Allostery is funda-
mental for kinase regulation (26,27). Some kinases, such
as PDK1 and Aurora A kinase, harbor an allosteric pocket
within the kinase domain (28). Other kinases regulate their
activities either through dimerization, e.g. EGFR kinase
(29), or through complex formation with binding partner
proteins, such as the independently expressed regulatory
subunits of the protein kinase A (PKA) holoenzyme (30).
Because of their crucial role in multiple diseases, kinases
are attractive targets for inhibitor design (31) and small mol-1834 Biophysical Journal 119, 1833–1848, November 3, 2020ecules targeting allosteric regulatory sites offer improved
specificity in comparison to compounds solely targeting
conserved ATP-binding sites. Consequently, a number of
recent drug discovery efforts toward kinases focus on the
unique allosteric modalities of kinases (28). Thus, there is
a need for an effective strategy to quantitate combinatorial
allosteric effects in kinases in a physiologically relevant
context in which ligands occupy the ATP-binding site and,
additionally, a substrate-binding or anchoring site. This
study describes such a strategy.
PDK1 is a master kinase downstream of the PI3-kinase
and the growth factor signaling pathway. It is responsible
for phosphorylation of other AGC-family kinases, including
Akt/PKB, S6K, PKA at their activation loops, resulting in
kinase activation and stimulation of their individual down-
stream pathways (32–35). PDK1 contains two ligand-bind-
ing sites in the N-terminal lobe: the orthosteric ATP-binding
pocket and a regulatory allosteric site called the PIF-pocket
(‘‘O’’ and ‘‘A,’’ respectively, Fig. 1, A and B). As the primary
interaction site for ATP, ‘‘O’’ is the critical orthosteric site
fundamental to kinase catalysis. PDK1 activity is further
regulated by the docking of C-terminal hydrophobic motif
of a subset of its substrates such as S6K and PKC at the
PIF-pocket, which elicits allosteric changes across both
lobes of the kinase. A peptide ligand (PIFtide), as well as
a number of small-molecule activators have been developed
that bind at the PIF-pocket and enhance PDK1 kinase activ-
ity (36–40). These PIF-pocket ligands can be designed to
function as selective allosteric modulators/inhibitors for
substrates requiring docking at the PIF-pocket. Addition-
ally, a reverse allosteric effect upon adenosine binding at
the ATP-pocket of PDK1 was found to enhance binding of
PIFtide (41). PDK1 and its sets of ligands thus offer a unique
set of two ligands binding to a single target protein to
monitor and quantitate allosteric coupling. (Fig. 1 A).
In this study, we have mapped the allosteric coupling be-
tween ATP- and PIF-pockets in PDK1. Our results reveal
that HDXMS offers a quantitative readout of synergism in
intraprotein allosteric networks, i.e., enhanced changes in
conformation and dynamics arising from concurrent binding
of ligands at two sites. Furthermore, we uncover a kinase-
specific allosteric mechanism in which a conserved lysine
on b-3 strand (Lys72 in protein kinase A (42)) functions
as an integrator node for convergence and integration of
allosteric signals from distinct ligand-binding sites.MATERIALS AND METHODS
Key materials
Ni-NTA Sepharose resin was from GE Healthcare (Chicago, IL). Insect cell
expression system and all the insect-cell-related material were from Invitro-
gen (Thermo Fisher Scientific, Waltham, MA). Site-directed mutagenesis
was performed using a QuikChange strategy (Agilent Technologies, Santa
Clara, CA). PIFtide (REPRILSEEEQEMFRDFDYIADWC) is a peptide
derived from the hydrophobic motif of PRK2 (a PDK1 substrate) synthesized
FIGURE 1 Basis for allosteric crosstalk between
the two noncontiguous ligand sites of PDK1 kinase.
(A) Kinase domain of PDK1 in cartoon representa-
tion showing the N- and C-terminal lobes and loops
critical for catalysis of phosphotransfer activity:
HRD motif loop (purple) and activation loop
(olive). Two ligand binding sites at the small lobe
are marked ‘‘O’’ for the orthosteric ATP-binding
pocket and ‘‘A’’ for its corresponding allosteric
PIF-pocket. A double-headed arrow between
them indicates bidirectional allostery. The interplay
between PDK1 dynamics and the allosteric effects
of ligand binding at either site is unknown. (B)
Structure of PDK1 bound to ATP and PS48
(PDB: 3HRF (38)) showing ATP- (salmon) and
PIF-pocket sites (green). Binding ligands are
blue. Important secondary structure elements of
the kinase are highlighted: b-1 strand, G-rich loop
and the hinge region at the ATP-binding pocket
(salmon), the HRD motif loop (purple), b-3 strand
and activation loop (olive), and PIF-pocket (aB,
aC, and b-4) (green). Shown is a close-up of
ATP- (C) and PIF-pocket (D), with important or-
thosteric contacts at the ATP-pocket (using adeno-
sine-bound PDK1 (PDB: 5LVN)) and PIF-pocket
(using PDK1-ATP-PS48 complex structure (PDB:
3HRF)). (E) Deuterium exchange heatmaps
showing relative fractional deuterium uptake
(data uncorrected for back exchange) in apo-
PDK1 ranging from 0 to a maximum of 0.7
(PDB: 3HRF). Shown is a 180 view of apo-
PDK1 heatmap at deuterium exchange time (t ¼
1 min). Ligands are shown only to demarcate the
two pockets. To see this figure in color, go online.
Quantitating Synergistic Allosteryby Pepscan (Lelystad, the Netherlands). Deuterium oxide (D2O) for HDXMS
was from Cambridge Isotope Laboratories (Tewksbury, MA). Water, aceto-
nitrile, and methanol for liquid chromatography coupled to mass spectrom-
etry (LC-MS) were from Thermo Fisher Scientific. Trifluoroacetic acid
was from Fluka Biochemica (Buchs, Switzerland). All other reagents and
chemicals were obtained from Sigma-Aldrich (St. Louis, MO).Purification of PDK1 protein kinase
Although dimerization of full length PDK1 has been described (43–45),
there is no report suggesting dimerization or oligomerization of the
PDK1 catalytic domain by itself. We have previously purified PDK1 cat-
alytic domain (residues 50–359) and reported on its properties exten-
sively (37,38,46), and it elutes as a single Gaussian peak
corresponding to the estimated molecular weight of the monomer. How-
ever, it crystallizes in crystal packing I, with the PIF-pocket occupied by
Tyr288 of a neighboring molecule (46). To avoid this potential crystalli-zation artifact, the PDK1 protein used in this study is PDK1 50–359
[Y288G,Q292A], which elutes as a single monomer with an unambigu-
ous Gaussian elution profile in size-exclusion chromatography and crys-
tallizes in a different packing (38). Adenosine, PIFtide and other
compounds tested produced the same effects on wildtype and PDK1
[Y288G,Q292A] mutant (38,41), indicating that this motif does not
impact the effects described in this study.
PDK1 50–359 [Y288G,Q292A] was purified as previously described
(38). In brief, the His-tagged recombinant protein was purified through
Ni-NTA affinity chromatography, followed by a 4-h dialysis in buffer A
(50 mM Tris-HCl (pH 7.4), 500 mMNaCl, PMSF, and 0.02% b-mercaptoe-
thanol) to remove excess imidazole. The hexahistidine tag was then cleaved
by overnight incubation with TEV protease at 4C and affinity purified
through a second Ni-NTA resin to recover the flowthrough consisting of
cleaved PDK1 50–359 alone. After a final gel filtration chromatography
step using buffer B (20 mM Tris-HCl (pH 7.4), 500 mM NaCl, and
1 mM DTT), the purified protein fractions were pooled and concentrated
to 1.1 mg/mL (31 mM), aliquoted, flash frozen in liquid nitrogen, and storedBiophysical Journal 119, 1833–1848, November 3, 2020 1835
Ghode et al.at 80C until HDXMS analysis. The gel filtration chromatography profile
for purification of PDK1 is shown in Fig. S1.Amide hydrogen-deuterium exchange
Amide hydrogen-deuterium exchange reactions were initiated by diluting
apo PDK1 (unliganded) and under various ligand-bound conditions in buffer
B reconstituted in D2O (pHread 7.4). Ligand concentrations used ensured
>98% ligand bound to PDK1. PIFtide stock solution (400 mM)was prepared
in 50 mM Tris (pH 7.4), adenosine stock solution (20 mM) was prepared in
water. Of these stocks, 1 mL PIFtide and 2 mL adenosinewere used per deute-
rium exchange reaction to achieve a final reaction concentration of 10 mM
and 1 mM, respectively. Deuterium exchange was initiated by dilution of
1 mL of PDK1 with 39 mL of dilution buffer, prepared using buffer B recon-
stituted in 99% D2O (36 mL), 3 mL ligand stock solution in buffer B in H2O,
to achieve a final D2O concentration of 90% in all the reactions. This premix-
ing of ligands with buffer B in D2O ensured protein was not exposed to high
concentrations of ligands before dilution in deuterium exchange buffer.
Deuterium exchange reactions were carried out for apo, single-ligand-
bound (adenosine, PIFtide) and two-ligand-bound (adenosine and PIFtide)
PDK1 for times, t ¼ 0.5, 1, 5, 10, and 100 min as they span both fast and
slow deuterium exchange regimes (47). All reactions were carried out at
30C, and quenched using 10 mL prechilled solution (0.5% trifluoroacetic
acid, 5 M GnCl) to achieve a pHread of 2.5. All deuterium exchange reac-
tions were carried out in triplicates, along with 10 undeuterated reactions
for peptide identification.LC-MS
Quenched deuterium exchange reactions were immediately injected into
nanoUPLC HDX Sample Manager (Waters Corporation, Milford, MA)
for online pepsin digestion using Poroszyme prepacked pepsin column
(Applied Biosystems, Foster City, CA), using 0.1% formic acid in LC-
MS water at 100 mL/min. The eluted peptides were then trapped and de-
salted by a VanGuard C-18 column (Waters Corporation), followed by
reverse-phase separation using ACQUITY 2.1  5 mm BEH C-18 column
(Waters Corporation) using a 8–40% gradient of 0.1% formic acid in aceto-
nitrile flowing at 40 mL/min using nano-ACQUITY binary solvent manager
(Waters Corporation).
Eluted peptides were analyzed by Synapt G2 Si mass spectrometer (Wa-
ters Corporation) operating in positive ion mode using an MSE acquisition
method (48,49). The mass spectrometer was continuously calibrated using
200 fmol/mL Glu-Fibrinopeptide B standard flowing at 1 mL/min. All other
parameters for pepsin digestion and LC-MS were same as described (50).HDXMS data analysis
Peptides of PDK1 inmass spectrometry datawere identified from 10 separate
pepsin digests of aqueous PDK1 (undeuterated) by ProteinLynx Global
Server 3.0 software (Waters Corporation), searching against a human PDK1
sequence database from UniProt (UniProt: O15530) residues 50–359 along
with substitution of two residues to account forY288GandQ292Amutations.
We then applied the followingfilters for PDK1 reporter peptides forHDXMS:
minimal signal intensity, 5000; maximal sequence length, 25 residues; mini-
mal fragmentation products per amino acid, 0.2; mass tolerance, 10 ppm; and
present in aminimumof threeout of 10 replicate digests. Spectral peak assign-
ment and calculation of deuterium uptake was performed using DynamX 3.0
software (Waters Corporation, Milford, MA). Only 35 peptides with high
signal/noise ratios were analyzed yielding a total 89% sequence coverage
and an average redundancy of 1.56. Deuterium uptake was calculated by Dy-
namX3.0 as the shift in centroids of individual spectral profiles relative to that
of the undeuterated peptide. This difference in centroid in each deuterium-
exchanged peptide represents the average increase in deuterium exchange1836 Biophysical Journal 119, 1833–1848, November 3, 2020with time. The deuterium uptake values reported in this study are uncorrected
for back exchange, with 30% average back exchange for our experimental
setup (51). A summary of the data analysis statistics is described in Table S2.
The list of peptides, charge states and deuterium exchange values for the pep-
tides in apo, individually ligand-bound and dual-ligand-bound states are
shown in Tables S3 and S4.
Deuterium exchange time and difference plots were generated by Dy-
namX 3.0. Deuterium difference plots compare deuterium uptake values
for each peptide from one state to the other as mentioned and are plotted
against individual peptides listed from N- to C-terminus along the x axis.
Because deuterium uptake values for each peptide are an average of three
replicates, the maximal standard errors for all peptides are shown in gray
in all deuterium exchange difference plots. All difference plots follow the
convention of difference between ligand-bound minus ligand-free states,
respectively, in which negative difference at the site for ligand indicated
in bold (O for adenosine, A for PIFtide) represents ligand binding induced
protection from deuterium exchange.Structure-based statistical mechanical model of
allostery
The structure-based statistical mechanical model of allostery (SBSMMA),
which accounts for the causality of allosteric communication upon pertur-
bations such as ligand binding and/or mutations (10,12,52), was used in this
study. Here, allosteric signaling caused by binding of adenosine PIFtide
and, upon perturbation at Lys111 (identified from HDXMS mapping of
PDK1 allostery), was quantified in terms of the energetics using the Allo-
SigMA web-server (53).
The crystal structure of PDK1 kinase domain complexed with both ATP
and PS48 (Protein Data Bank, PDB: 3HRF) was used to construct the Ca-
harmonic models for both unperturbed (0) and perturbed (P) states of the









where dr represents the 3N-dimensional vector of displacements of Ca-
atoms relative to the reference structure. The distance between Ca-atoms
i and j and the corresponding distance in the reference structure are dij
and d0ij , respectively. The distance-dependent force constant kij  ð1=d0ijÞ6
stipulated a global distance cutoff at 25 Å (54). Perturbation mimicking
ligand binding to a site S is modeled by an additional harmonic restraining
term a ¼ 100 to the force constants of all pairs of residues constituting S.
Similarly, alteration of the local interactions between a single residue m
and its neighbors j is simulated by increasing ðq¼ 100Þ or decreasing
ðq¼ 0:01Þ the force constants, which gives
EðPÞðdr; S; mÞ ¼
X




















Next, two sets of low-frequency normal modes eð0Þm and e
ðPÞ
m , character-
izing the configurational ensembles of the corresponding states are ob-
tained. The normal modes m are then used to calculate the per-residue
allosteric potential for each state, which evaluates the total elastic work
experienced by a residue i as a result of changes in the displacements of








Quantitating Synergistic Allosterywhere s represents a configurational state and εm;i ¼P
j: d0i;j < dc
em;i  em;j
 2. In the last step, briefly, integrating over the
ensemble of all configuration states of a residue i allows calculation of
the corresponding free energies, and therefore the change in free energy












More detailed descriptions can be found in previous work (12,52). To es-
timate the background-free effect, the per-residue allosteric modulation
Dh
ðPÞ
i is calculated by the deviation of the free energy change Dg
ðPÞ
i from
its average value over all residues of the protein chain. A positive allosteric
modulation Dh
ðPÞ
i indicates an increase of configurational work exerted on
residue i due to a perturbation P, potentially leading to conformational
changes, whereas a negative one may prevent conformational changes via
stabilization of the residue. As mentioned above, the allosteric response
due to the weakening ðYÞ or a strengthening ð[Þ of the local interactions
of single residues can be quantified using the SBSMMA. To evaluate the
allosteric effect emanating from Lys111, the modulation range Dh
ðLysY[Þ
i ,
which provides a generic description of the maximal strength of allosteric
signaling (12), was obtained from the difference in modulations caused by
the opposite scenario. These per-residue Dhi-values were used to generate
plots of configurational work against residue numbers arranged along the x
axis (Figs. 6 E and S1, A and B). These values were also used to generate
SBSMMA heat maps (Fig. 6 D and S1, C and D). Allosteric responses
on the level of sites Dh
ðPÞ
site can be obtained by averaging the modulation
values of all residues belonging to a site of interest (Table S1).RESULTS
Mapping allosteric signatures of adenosine and
PIFtide binding to PDK1
PDK1 contains two spatially distinct ligand-binding sites
(38) on the small N-lobe of the kinase (Fig. 1, A and B),
labeled ‘‘O’’ for orthosteric ATP/adenosine binding site
and ‘‘A’’ for an allosterically coupled distal site (PIF-
pocket). In turn, ‘‘A’’ corresponds to the orthosteric site
for PIFtide and ‘‘O’’ is its known allosterically coupled
distal site. Orthosteric contacts for ligand binding at either
pocket (Fig. 1, C and D) are defined based upon distance
constraints (typically %5 Å) obtained from structural coor-
dinates. Such distance constraints do not reflect the true en-
ergetic contributions of individual residues for maintenance
of protein-ligand complexes in solution. The energetic con-
tributions to protein-ligand and protein-protein interfaces
are mediated by smaller subsets of the total number of prox-
imal contacts, as shown by alanine scanning mutagenesis
(55) or HDXMS (20,56). To map key PDK1 residues that
contribute to the interface with adenosine or PIFtide at their
respective noncontiguous binding sites, we carried out
comparative HDXMS of apo and ligand-bound PDK1.
HDXMS of apo PDK1 at deuteration times, t ¼ 0.5–
100 min were carried out as described in Materials and
Methods. Relative deuterium exchange in all peptides
were mapped onto the structure of PDK1-ATP-PS48 com-
plex (PDB: 3HRF (38)) to generate a deuterium exchange
heatmap (Fig. 1 E). Loop regions expectedly showed greaterrelative deuterium exchange in apo PDK1, whereas ATP-
and PIF-pockets showed both high and low relative deute-
rium exchange at all time points of deuterium exchange.
A deuterium exchange difference plot (Fig. 2 A) shows
changes in deuterium exchange across PDK1 upon adeno-
sine binding with decreased deuterium exchange broadly
across all identified orthosteric contact residues (‘‘O’’).
Deuterium exchange time plots for representative peptides
are shown (Fig. 2, B–D).
Allostery upon adenosine binding was detected in the
distal ‘‘A’’ site, with increased deuterium exchange in pep-
tide 115–130 (aB þ aC helix), but no changes in 122–
134 (aC helix, Fig. 2 A). Increased deuterium exchange
seen at aB helix is consistent with molecular dynamics sim-
ulations (41). The b-4 strand peptide 146–155 and part of
the ‘‘A’’ site showed decreased exchange upon adenosine
binding (Fig. 2, A and E–G). Importantly, a large decrease
in HDXMS at peptide 108–114 was observed after
100 min deuterium exchange, and its significance is dis-
cussed at the end of this section. Increased deuterium ex-
change was also observed at additional distal loci in
peptides 67–81, 168–177, activation loop (225–247), and
254–265. The C-terminal GHI-subdomain of the kinase
also presented two allosteric loci with altered deuterium ex-
change in peptides 292–311 and 317–329 (Fig. 2 A, boxed
gray). Overall, five peptides spanning the orthosteric ATP-
binding site showed decreased deuterium exchange due to
adenosine binding, one peptide of PIF-pocket showed
increased and two peptides showed decreased deuterium ex-
change. At sites distal to both pockets, one peptide each
showed increased and decreased exchange in the adeno-
sine-bound state. Importantly, adenosine binding resulted
in changes in deuterium exchange in its known ‘‘A’’ site
and in catalytically important regions of the kinase
including the b3 strand. The C-lobe GHI-subdomain was
additionally identified as a new allosteric hotspot for
adenosine.
Interactions of PIFtide with the PIF-pocket of PDK1 were
similarly mapped by HDXMS. PIFtide-bound PDK1
showed deuterium exchange protection at all three subsites
of PIF-pocket (‘‘A,’’ Fig. 3 A). The aB-aC helices with high
intrinsic deuterium exchange, as well as the b-4 strand
showed decreased deuterium exchange in PIFtide-bound
PDK1 (Fig. 3, B–D). PIFtide binding also resulted in
decreased deuterium exchange at the HRD-motif loop
(193–212) of the ATP-binding pocket, with no changes at
other subsites forming the ATP-pocket (Fig. 3, A and
E–G). This decrease in deuterium exchange at ATP-pocket
by PIFtide binding is an opposite effect to the increased ex-
change in the aB helix of PIF-pocket elicited by adenosine
binding and highlight an asymmetry in the allosteric effects
observed with these two cooperative ligands. Together,
these results indicated that for adenosine and PIFtide, all
subsites of the two ligand-binding pockets were not equiva-
lently allosterically coupled as measured by deuteriumBiophysical Journal 119, 1833–1848, November 3, 2020 1837
FIGURE 2 Orthosteric and allosteric changes upon adenosine binding. (A) Deuterium exchange difference plot (deuterons versus peptic cleavage peptides
represented from the N- to C-terminus) comparing differences in deuterium exchange between adenosine-bound and apo PDK1 at different deuterium ex-
change time points, as indicated in key. Each difference value is an average of three replicates, with standard errors for each peptide plotted as a gray curve
along the y¼ 0 line. Peptides spanning residues lining the ATP-pocket (‘‘O’’) and PIF-pocket (‘‘A’’) are boxed brown and green, respectively. (B–D) Semilog
deuterium uptake plots (deuterons exchanged with time (minutes)) for selected peptides spanning residues lining the ATP-pocket for apo (red) and adenosine-
bound (black) PDK1. (E–G) Deuterium exchange differences between adenosine-bound and apo-PDK1 at t¼ 1, 10, and 100 min, respectively, mapped to the
structure of PDK1-ATP-PS48 complex (PDB: 3HRF). Decreased and increased exchange are indicated in gradients of blue and red, as per key. See also
Fig. S2; Tables S1 and S3. To see this figure in color, go online.
Ghode et al.exchange. For adenosine and PIFtide, only the HRD-motif
loop of the ATP-pocket, aB helix, and b-4 strand of the
PIF-pocket showed corresponding allosteric changes in
deuterium exchange.1838 Biophysical Journal 119, 1833–1848, November 3, 2020Changes in deuterium exchange due to PIFtide binding
were also observed in b-3 strand (108–114, discussed in a
later section), the activation loop (225–247), as well as
the two GHI-subdomain loci (292–311 and 320–329).
FIGURE 3 Orthosteric and allosteric changes upon PIFtide binding. (A) Deuterium exchange difference plot (deuterons versus peptic cleavage peptides
displayed from the N- to C-terminus) comparing differences in deuterium exchange between PIFtide-bound and apo PDK1 at different deuterium exchange
time points, as indicated in key. Axes, time points, error curves, and highlighted regions of interest are similar to Fig. 2 A. (B–D) Semilog deuterium uptake
plots showing deuterons exchanged with time (minutes) for selected peptides spanning residues lining the PIF-pocket for apo (red) and PIFtide-bound (green)
PDK1. (E–G) Deuterium exchange differences between PIFtide-bound and apo-PDK1 at t ¼ 1, 10, and 100 min, respectively, mapped to structure of PDK1-
ATP-PS48 complex (PDB: 3HRF). Regions showing decreased exchange are indicated in shades of blue, whereas those showing increased exchange (positive
differences) in shades of red, as per key. See also Fig. S2; Tables S1, S3, and S4. To see this figure in color, go online.
Quantitating Synergistic AllosteryInterestingly, both adenosine and PIFtide binding elicited
similar changes in deuterium exchange at the two GHI-sub-
domain loci. Overall, PIFtide binding resulted in decreased
deuterium exchange at five peptides of the PIF-pocket andtwo peptides of the ATP-pocket. At GHI-subdomain sites
distal to both pockets, one peptide each showed increased
and decreased deuterium exchange in PIFtide-bound
PDK1.Biophysical Journal 119, 1833–1848, November 3, 2020 1839
FIGURE 4 Combinatorial allostery in PDK1 upon ligand binding at both ATP- and PIF-pockets. (A–B) Deuterium exchange difference plots of PDK1
bound to both PIFtide and adenosine relative to singly liganded PDK1. Axes, time points, error curves, and highlighted regions of interest are as per
Fig. 2 A. Decreased deuterium exchange at 193–212 (ATP-pocket, salmon) in (A) and 115–134 (PIF-pocket, green) in (B) reflect cooperatively enhanced
binding of adenosine and PIFtide, respectively, in the presence of the corresponding cooperative ligand. (C) Semilog deuterium uptake plots for
(legend continued on next page)
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Quantitating Synergistic AllosteryTo model the energetics of allosteric coupling between
the two noncontiguous ligand-binding sites of PDK1, we
applied the SBSMMA, which describes allosteric communi-
cation generated by perturbations such as ligand binding
and/or mutations (12,52). The SBSMMAmodels the protein
as a network of spheres positioned at the C a-atoms and an-
alyzes the normal modes of their harmonics using a dis-
tance-dependent force constant, without taking into
consideration residue type or any specific interactions.
The readout of allosteric response from SBSMMA is in
the form of configurational work, Dhi (kcal/mol), calculated
for each residue i of the protein. Positive modulation, i.e.,
Dhi > 0, is indicative of conformational changes in response
to the allosteric perturbation. Indeed, conformational
changes taking place as a result of the allosteric signaling
can lead to changes in the structural dynamics and in the
ensemble distribution of sampled conformations. In the
case of a shift in the conformational ensemble toward
more closed structures at the site of HDXMS measurement,
decreased deuterium exchange can be expected, whereas a
shift toward more open structures would result in a localized
increase in deuterium exchange. On the other hand, a nega-
tive Dhi is an indicator of decrease in configurational work,
i.e., allosteric stabilization that may result in either a similar
or reduced deuterium exchange.
We performed SBSMMA analysis for adenosine and PIF-
tide binding to PDK1 as described in the Materials and
Methods, and observed that adenosine binding generated
negative Dh-values for b-4 strand (0.23 kcal/mol), with
only minor changes at aB and aC helices (0.05 and
0.11 kcal/mol, respectively) (Fig. S2 A; Table S1). PIFtide
binding resulted in a negativeDh for b-1 strand and Gly-rich
loop (0.65 kcal/mol) and a positive Dh at the hinge loop
and the HRD-motif loop (0.11 and 0.27 kcal/mol respec-
tively) (Fig. S2 B; Table S1). Furthermore, both ligands re-
sulted in strong allosteric effects at the large lobe of PDK1,
including the GHI-subdomain loci (Table S1). Importantly,
results from SBSMMA aligned well with HDXMS results.
Heat maps of these Dh-values (Fig. S2, C and D) confirm
these loci as common hotspots of allostery by these ligands.aB and aC helices, HRD-motif loop, and GHI-
subdomain are hotspots of combinatorial
allostery
We next mapped orthosteric and allosteric effects in dual-
ligand-bound PDK1 (adenosine and PIFtide) by HDXMS.
A deuterium exchange difference plot of PDK1-adeno-
sine-PIFtide ternary complex with apo-PDK1 (Fig. S3)
showed deuterium exchange protection at both ligandrepresentative peptides that show enhanced protection from deuterium exchang
deuterium exchange in apo-, PIFtide-bound, adenosine-bound, and both (adenos
of PDK1-ATP-PS48 complex (PDB: 3HRF) in the center highlights the loci reve
see this figure in color, go online.pockets as well as at one of the GHI-subdomain loci. A
deuterium exchange difference plot of PDK1-adenosine-
PIFtide ternary complex with PDK1-adenosine complex
(Fig. 4 A) showed decreased exchange at the HRD-motif
loop (193–212) alone, whereas the other ‘‘O’’ subsites b-1
strand and Gly-rich loop (82–93) and hinge loop
(161–167) showed no change. Difference plot comparing
exchange in the ternary complex with PDK1-PIFtide com-
plex (Fig. 4 B) showed decreased exchange at aB-aC heli-
ces (115–134) of the PIF-pocket (‘‘A’’), whereas b-4 strand
peptides (146–155) showed no difference.
Furthermore, one of the two GHI-subdomain loci
(320–329) showed enhanced deuterium exchange protection
due to concurrently bound ligands relative to individual-
ligand-bound states, indicating an integrative combinatorial
effect in the adenosine and PIFtide-bound state (Fig. 4 C).
Overall, a comparison of deuterium exchange in the
dual-liganded complex relative to adenosine-bound PDK1
indicated additional decreases in exchange in two peptides
alone of ‘‘O’’ site. In contrast, all peptides at the ‘‘A’’ site
showed a decreased exchange due to PIFtide binding. At
sites distal to both pockets, five peptides showed larger de-
creases in exchange. Similarly, for ternary complex relative
to PIFtide-bound PDK1, three peptides of ‘‘A’’ site showed
decreased exchange, and five peptides of ‘‘O’’ site showing
decreased exchange due to adenosine binding. However,
only three peptides distal to both pockets showed a nega-
tive difference.Allosteric coupling factor for quantitation of
synergistic allosteric effects
A comparison of deuterium exchange differences between
doubly liganded versus singly liganded PDK1 showed
certain loci where effects of both ligands were more pro-
nounced than at other spots. To map and quantitate syner-
gism in the allosteric effects of the two cooperative
ligands (adenosine and PIFtide), we assessed any added
deuterium exchange protection observed with both ligands
bound, relative to that seen in singly liganded states. We
postulate that deuterium exchange in the doubly liganded
state offers a direct readout of the synergistic allosteric ef-
fects because of combined effects of both ligands. We define
a term, allosteric coupling factor (ACF), to denote the deute-
rium exchange difference in the doubly liganded state (rela-
tive to the apo state) (C) minus the sum of deuterium
exchange differences in singly bound states (relative to the
apo state):
ACF ¼ C--ðOþAÞe in presence of both ligands. Red, green, black, and purple plots represent
ine þ PIFtide)-bound PDK1, respectively, as indicated in the key. Structure
aling combinatorial allosteric effects. See also Fig. S3; Tables S3 and S4. To
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TABLE 1 Allosteric Synergism across PDK1-Adenosine-
PIFtide Complex
Peptidea Siteb MEAc
Allosteric Coupling Factord C – (O þ A)
0.5 min 1 min 5 min 10 min 100 min
115–130 aB 14 1.5* 1.4 0.9 0.6 0.4
122–134 aC 11 0.9 1.2* 1.1 0.8 0.1
122–130 aC 7 0.9* 0.8 0.1 0.0 0.1
108–121 b3 þ aB 13 0.7* 0.7 0.6 0.3 0.8
193–210 HRD 16 0.2 0.2 0.2 0.3 0.7*
194–212 HRD 17 0.1 0.1 0.2 0.3 0.6*
67–81 N-term 9 0.5* 0.5* 0.2 0.3 0.3
72–81 N-term 6 0.4 0.5* 0.3 0.2 0.3
216–224 DFG 8 0.3 0.4* 0.1 0.1 0.1
317–329 GHI 12 0.1 0.2 0.1 0.1 0.3*
146–155 b4 9 0.3* 0.1 0.2 0.2 0.5
146–152 b4 6 0.2* 0.1 0.1 0.2 0.5
320–329 GHI 9 0.1* 0.1 0.1 0.1 0.1*
N-term, N-terminus.
aPDK1 peptides showing synergistic allostery ranked in increasing order of
negative ACF. The lowest ACF-values for each peptide across deuterium
exchange time points are marked by asterisks.
bSecondary structural loci on PDK1 kinase
cNumber of maximal exchangeable amide (MEA) hydrogens in the peptide,
calculated by subtracting the number of Prolines and 1 (for the N-terminal
residue) from the total number of residues in the peptide.
dACF, defined as the composite difference in deuterium exchange protec-
tion in doubly-bound PDK1 (C) minus the added decreased exchange in
singly adenosine (O) and PIFtide (A) bound PDK1 relative to apo-PDK1.
Negative values reflect stabilizing effects due to concurrent binding of
two ligands.
FIGURE 5 For a Figure360 author presentation of this figure, see https://
doi.org/10.1016/j.bpj.2020.09.019
Hotspots of synergistic allostery detected by ACF span crucial kinase mo-
tifs. (A) Heat map of synergistic allosteric effects due to dual adenosine and
PIFtide binding to PDK1 as calculated by ACF mapped onto PDK1-ATP-
PS48 complex (PDB: 3HRF), with ligands in green and yellow. The extent
of synergism is denoted by shades of red as per key (more negative ACF
equals greater synergism). Residues spanning catalytically crucial motifs
of the kinase that showed synergistic effects are shown as cyan spheres.
(B) Cartoon representation of PDK1 showing the observed combinatorial
bidirectional allosteric effects upon dual ligand binding at the two pockets,
catalytic sites, and distal GHI-subdomain locus. See also Tables S3 and S4.
To see this figure in color, go online.
Ghode et al.ACF offers a readout of allosteric synergism across different
PDK1 peptides with differences in deuterium exchange (O,
A, and C) relative to apo-PDK1. Negative and positive ACF,
in turn, denote synergistic stabilization or destabilization at
any peptide.
Positive ACF-values were not observed for any PDK1
peptide indicating no synergistic destabilization in
doubly liganded PDK1. Peptides of PDK1 that showed
synergistic allosteric stabilization with PIFtide and aden-
osine are summarized in Table 1, ranked in decreasing
ACF for all deuterium exchange times. Broadly, ACF-
values followed the same pattern with time as in singly
bound states where, in high-exchanging peptides, the
magnitude of ACF was most negative at early time
points and low-exchanging peptides showed greatest
magnitude ACF-values at longer deuterium exchange
times.
Overall, peptides spanning aB and aC helices of PIF-
pocket showed the highest magnitude of negative ACF-
values, indicative of strong synergism (1.5 for peptide
115–130 and 1.2 for 122–134), followed by catalytic/
HRD-motif loop of the ATP-pocket (0.7 for 193–210).
N-terminal peptides (0.5 for peptide 67–81) and loop
containing the catalytic DFG-motif (0.4 for peptide
216–224) were additional hotspots of synergistic allostery
based on magnitude of ACF. Furthermore, we found that
b-4 strand of PIF-pocket (0.3 for peptide 146–155) and1842 Biophysical Journal 119, 1833–1848, November 3, 2020the GHI-subdomain locus (0.3 for 317–329, 0.1 for
peptide 320–329) showed ACF-values of smallest magni-
tude, and therefore represent regions with smallest syner-
gistic effects. Importantly, ACF magnitudes correlated
with the most catalytically critical regions of the kinase:
aB-aC helices, b-3 strand, HRD and DFG motifs (Fig. 5,
A and B; (57,58)).Lys111, a critical lynchpin residue for integration
of allosteric signals
Deuterium exchange plots for adenosine and PIFtide singly
bound to PDK1 showed a sharp drop in deuterium exchange
for the b-3 strand peptide (108–114) at t ¼ 100 min alone
(Figs. 2 A and 3 A). A combined difference plot, showing
deuterium exchange differences at t ¼ 100 min for adeno-
sine, PIFtide, and both ligand-bound PDK1 relative to apo-
PDK1 (Fig. 6 A), highlights this reduction in HDX. A deute-
rium uptake plot for this peptide (Fig. 6 B) shows slow ex-
change up to t ¼ 10 min (1.1 D) with a jump in
exchange after 100 min (2.7 D). After 100 min exchange,
protection was observed with both singly bound adenosine
and PIFtide (1.1 and 1.0 D, respectively). In the doubly li-
ganded state, a bigger decrease in exchangewas seen (0.8 D).
The b-3 strand, an important element in all kinases, is
sandwiched between the two ligand-binding sites within
the small lobe of the kinase. It contains a conserved
FIGURE 6 Lys111 integrates allosteric signals from both ATP- and PIF-pockets. (A) Difference plot comparing protein-wide differences in deuterium
exchange between ligand-bound and apo PDK1 at t ¼ 100 min, with indicated ligand(s) bound as per key. Axes and error curves are similar to the difference
plots in Fig. 2. Peptide 108–114, highlighted in red box, spans the b-3 strand and shows significant protection only at 100 min. (B) Semilog deuterium ex-
change plot of the peptide 108–114 in apo, adenosine-, and PIFtide-bound states, as shown in key below. Presence of either ligand decreases exchange in the
peptide after 100 min. (C) A network of interactions between the conserved Lys111 on b-3 strand and conserved Glu130 of aC helix of the PIF-pocket, as
well as the a-phosphate of ATP in PDK1 (PDB: 3HRF). (D) Heatmap of the allosteric configurational work ðDhiÞ due to Lys111 modulation, as calculated
using SBSMMA, with blue indicating negativeDhi, whereas red is positive. (E) A plot ofDhi output from SBSMMA for Lys111 perturbation, withDhi along
y axis and PDK1 residues along x axis. See also Tables S3 and S4. To see this figure in color, go online.
Quantitating Synergistic Allosterylysine (Lys111) that mediates an important salt bridge
interaction with the a-phosphate of ATP on one side
and a conserved glutamate (Glu130) of the aC helix of
PIF-pocket on the other (Fig. 6 C). This salt bridge has
been clearly described in PKA (59). Our results suggestthat even in the absence of the phosphate moieties of
ATP, e.g. with adenosine, this conserved lysine and its
salt bridge with Glu130 connected bidirectional allosteric
relays between the ‘‘O’’ and ‘‘A’’ sites, functioning as an
integrator node.Biophysical Journal 119, 1833–1848, November 3, 2020 1843
Ghode et al.To further analyze the allosteric links between Lys111 and
the two noncontiguous ligand-binding sites, we performed
single-residue perturbation analysis for Lys111 using the
AlloSigMA web-server as described in Materials and
Methods. The results showed that perturbation of Lys111
induced strong allosteric effects at bothATP- andPIF-pockets
(Fig. 6, D and E) in the form of negative modulation
(Dh
ðLys111Y[Þ
ATPpocket ¼ 0:50 and DhðLys111Y[ÞPIFpocket ¼  0:58 kcal=
mol). This indicated that allosteric communication via
Lys111 was capable of promoting overall stabilization of
both pockets. Furthermore, the model predicted strong allo-
steric effects at the distal GHI-subdomain locus originated
by Lys111 perturbation ðDhðLys111Y[ÞGHIsubdomain¼ 0:36 kcal =molÞ
were similar to those observed with both PIFtide and adeno-
sine. These results strongly support the role of Lys111 as an
integrator node for allosteric signaling across the kinase
domain of PDK1.Disorder-to-order transitions at aB-aC helices for
kinase activation
A closer inspection of mass spectral profiles of deuterium-
exchanged peptides spanning the aB and aC helices (115–1844 Biophysical Journal 119, 1833–1848, November 3, 2020130 and 122–134) of the PIF-pocket revealed a character-
istic bimodal isotopic distribution with a low-exchanging
and a high-exchanging subpopulation (Figs. 7, S4, and
S5). This is reflective of EX1 deuterium exchange kinetics
and indicative of coordinated folding or unfolding events
(13,60). These helices exhibit disordered-like behavior in
solution in the apo state (38). Therefore, these two subpop-
ulations correspond to distinct well-folded and disordered
states within the conformational ensemble, with a high-
exchanging disordered state predominating in apo-PDK1
(Figs. 7, S4, and S5). Orthosteric binding of PIFtide induced
a shift in the ensemble toward a more ordered conformation.
Adenosine binding resulted in an ensemble shift toward a
more disordered state for the peptide 115–130, but not for
122–134. Thus, the allosterically induced disorder due to
adenosine binding was confined to aB helix alone. Further-
more, we observed the biggest shift toward the ordered state
in the dual-ligand state (Fig. 7). Through these shifts, it is
apparent that PIFtide preferentially binds adenosine-bound
PDK1, as allosteric destabilization at these helices caused
by adenosine enhances PIFtide binding. Together, these re-
sults show that the allosteric activation of kinase is driven by
a disorder-to-order switch in aB and aC helices,FIGURE 7 Disorder-order transitions in PDK1
aB and aC helices function as conformational
switches for kinase activation. Stacked mass spec-
tral envelope plots for two overlapping peptides,
115–130 and 122–134, spanning aB and aC helices
in different states at deuterium exchange time t ¼
0.5 min. Shift in centroids are relative to the undeu-
terated (aqueous) peptide. Bimodal isotopic distri-
butions can be resolved into low-exchanging
(blue) and high-exchanging states (orange). See
also Figs. S4 and S5. To see this figure in color,
go online.
Quantitating Synergistic Allosterycoordinated via the Lys111 integrator node. Increased heli-
cal order in aC helix would also stabilize the critical
Glu130-Lys111 salt bridge.DISCUSSION
Although a general understanding of allostery has greatly
improved with recent experimental and theoretical advances
(7), rational development of allosteric drugs has lagged (61).
Further, allostery has been examined in singly ligand-bound
states but has not been explored as a base for screening sec-
ond ligands for more targeted drug discovery. However,
doubly liganded states are especially relevant for pharmaco-
logical targets such as kinases, which share a conserved
ATP-binding pocket and diverse allosteric pockets. Syner-
gistic allosteric modulation using a combination of two
ligands presents a potential new starting point for 2-com-
pound combinatorial drug development. HDXMS is ideal
for mapping protein-ligand interfaces and dynamics of pro-
tein-ligand interactions because it simultaneously offers a
peptide-level readout of bidirectional allostery in protein ki-
nases. Using this approach, we have mapped combinatorial
effects of adenosine and PIFtide binding at corresponding
ligand-binding sites, identified a common distal allosteric
GHI-subdomain site that shows synergistic effects and
developed a method to quantify the composite allosteric ef-
fect across PDK1 to rank the hotspots of allosteric
synergism.
Protein kinases are important pharmacological targets
(31) and contain conserved ATP/ADP binding pockets regu-
lated by allosteric switches to fine-tune their enzymatic ac-
tivity (62). Most drug candidates are screened against the
unliganded apo protein and compounds identified target
the conserved ATP-binding pocket making them prone to
cross talk interactions with other kinases causing reduced
specificity and potency (31). Synergistic ligands to ATP-mi-
metics can be used to improve both these attributes (63,64).
Synergy or antagonism between the ligands binding at allo-
sterically linked sites can also be utilized to modulate inter-
actions between protein kinases and regulatory effector
proteins (65).
PDK1 with its extensive repertoire of site-specific ligands
is an excellent model system for studying combinatorial
allostery (37,38,41). Ligands targeting noncontiguous sites
of PDK1 afforded a reduction in deuterium exchange greater
than the sum of reduction generated by individual ligands.
ACF derived from these measurements enabled ranking of
hotspots of synergistic allostery in PDK1. The greatest syn-
ergism was observed at aB helix, aC helix, and the HRD-
motif loop sites of the two ligand pockets. A distal locus
in the C-terminal lobe at the GHI-subdomain (317–329)
also showed allosteric synergism (Table 1), revealing
long-range propagation of synergistic allosteric effects.
GHI-subdomain plays an important role in interactions
with protein substrates and allosteric regulators (58), andsynergism at this locus shows that ligands at ATP- and
PIF-pockets exert a combined allosteric control at the
GHI-subdomain. Furthermore, we identified two additional
loci of synergism: regions 67–81 (N-terminus) and 216–224
(DFG-motif loop), that were not readily identifiable from
deuterium exchange difference plots. Importantly, sites
with negative values of ACF correlated with the catalyti-
cally most important elements of kinases (57), highlighting
a strong allosteric coupling between the two ligands (Fig. 5).
The analysis presented here has major implications for
our fundamental understanding of allostery. Our results
show that partially liganded states of an enzyme are partially
primed states, and full functional activity requires binding
of two ligands at allosterically coupled sites making a singly
ligand-bound state, and not the apo state, a preferred starting
point for allosteric inhibitor screening/design. Rather than a
discrete inactive-active state binary, our results posit allo-
stery in proteins operates through a continuum of conforma-
tional substates within a broad ensemble (66). Thus, current
theoretical frameworks describing combinatorial allostery,
such as one based on discrete Boolean logic and end-states
(67), would need to account for synergistically enhanced
changes in protein conformation and dynamics.Cooperative allostery through asymmetric
conformational changes
It has been theorized that all cooperative allosteric effects
must be bidirectional and symmetrical (68), based on the
principle of microscopic reversibility. Bidirectional allo-
steric coupling between ATP- and PIF-pockets of PDK1 is
well established (38,41). Interestingly, our results revealed
that cooperative ligands binding at these sites induced asym-
metrical changes in dynamics at their corresponding allo-
steric hotspots: PIFtide induced stabilization at HRD-
motif loop of the ATP-pocket, and adenosine induced
increased disorder at aB helix of the PIF-pocket (Figs. 2,
3, and 6) necessary for enhanced PIFtide binding through
optimal positioning of residues from PIFtide. Moreover,
these results also indicated that not all orthosteric subsites
are allosterically coupled. Our results therefore provide
the first experimental evidence of asymmetric changes in
structural dynamics between allosterically linked sites.Proteins as soft matter for allosteric propagation
A more nuanced view of allostery incorporating both
conformational as well as dynamics changes has come to
the forefront in the last two decades (6,7). It has been pro-
posed that multiple ‘‘pathways’’ of interactions connect
two allosterically coupled sites in a protein (69), and bind-
ing of ligands at these sites alters the relative contribution
of each of these pathways to the allosteric link (70). Our re-
sults indicate allosteric coupling between small lobe (ATP-
and PIF-pockets) and large lobe (GHI-subdomain) of PDK1Biophysical Journal 119, 1833–1848, November 3, 2020 1845
Ghode et al.may not be connected entirely by well-defined pathways, as
we observed no differences in deuterium exchange across
many regions in the large lobe, but only at specific loci in
GHI-subdomain (Figs. 2 and 3). Additionally, we observed
synergism only at a single GHI-subdomain locus (Figs. 4
and 5). This suggests a hybrid model for allosteric propaga-
tion, comprising well-defined directional relays via charged
amino acid side chains, as well as more fluid, diffused inter-
actions through the C-lobe’s hydrophobic core. Propagation
of allostery through the ‘‘bulk’’ hydrophobic protein core
would resemble energy dissipation through soft matter
such as hydrogels (71).Integrator nodes in kinase allostery networks
In addition to its known orthosteric interactions with the a-
phosphate ofATP, our results showed that Lys111 plays a crit-
ical role in integrating bidirectional allosteric signals in singly
adenosine-bound PDK1 (Fig. 6) and doubly liganded states
(Fig. 7). This has been independently derived by SBSMMA
analysis in which Lys111 perturbation caused nonzero Dhi
at both ligand sites as well as the GHI-subdomain (Fig. 6
D). In a closely related kinase from the AGC superfamily,
PKA, substituting theb-3 strand lysine (Lys72)with histidine,
generated a classical ‘‘kinase-dead’’ mutant with altered
deuterium exchange kinetics (42). Substitution of this critical
lysine with any other amino acid was found to abolish allo-
steric relays arising from ATP binding. Additionally, we
have previously described a compound that binds at the
PIF-pocket of anotherAGCkinase, atypical PKC, and inhibits
its kinase activity by affecting the equivalent b-3 strand lysine
(72). We therefore postulate that this conserved lysine func-
tions as an integrator node for transduction of coordinated
allosteric signals across all protein kinases, as kinases retain
a number of conserved elements that allow extraction of
fundamental features such as the underlying allosteric net-
works (26). Both the b-3 strand lysine as well as the aC helix
glutamate are conserved among all protein kinases (22), as
well as the salt bridge between them (73). Furthermore, the
disorder-to-order conformational switch of aC helix (Fig. 7)
can be modulated by the Lys111-Glu130 salt bridge for allo-
steric kinase activation (59).
In summary, our results describe for the first time, to our
knowledge, a framework for quantitation of synergistic allo-
stery in doubly liganded kinases, and show that the combi-
natorial allosteric effects rely on integrator nodes and
nonuniform distribution of the hotspots of synergistic allo-
stery. This strategy will enable rational development as
well as screening of synergistic pairs of ligands for
enhanced therapeutic effects with lower cross-reactivity.SUPPORTING MATERIAL
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